Relationship between xanthine oxidase gene polymorphisms and anti-tuberculosis drug-induced liver injury in a Chinese population

被引:4
|
作者
Ai, Xin [1 ]
Huang, Hangxing [1 ]
Miao, Zhimin [1 ]
Zhou, Tao [1 ]
Wu, He [1 ]
Lai, Yong [1 ]
机构
[1] Dali Univ, Coll Pharm, Dept Pharmacol, 32 Jia Shi Bo Ave, Dali 671000, Yunnan, Peoples R China
关键词
Anti-tuberculosis drug; Liver injury; Genetic  polymorphism; Xanthine oxidase; Drug metabolizing enzymes; INDUCED HEPATOTOXICITY; N-ACETYLTRANSFERASE-2; GENE; MOLECULAR-CLONING; ADVERSE EVENTS; RISK-FACTORS; PYRAZINAMIDE; ASSOCIATION; METABOLITES; EXPRESSION; HEPATITIS;
D O I
10.1016/j.meegid.2021.104991
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study was designed to investigate the association of the xanthine oxidase (XO) polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury (ATDILI) in Chinese population. A total of 183 tuberculosis patients were enrolled. Patients with ATDILI were classified as cases and those without ATDILI were classified as controls. Genotyping for XO polymorphisms was determined by polymerase chain reaction and direct sequencing. The allele frequencies and genotype distribution was analyzed using the Chi square test to analyze the association between the gene polymorphisms and ATDILI. Binary logistic regression analysis was performed to assess the risk factors of ATDILI. A total of 21 patients were developed liver injury during antituberculosis treatment in this study, with an incidence of 11.48%. In genotype analysis, no significant difference was observed in the alleles and genotypes frequencies of the six SNPs between two groups (P 0.05). In haplotype analysis, carriers with GGGATA (rs1884725- rs2295475 -rs45523133- rs206812- rs206813rs7575607) haplotype had a significantly higher risk of ATDILI compared with other haplotypes (OR = 2.445, 95%CI: 1.058-5.652, P < 0.05). This study suggested that the haplotype GGGATA constructed with rs206812 and rs7575607 mutant alleles might contribute to ATDILI susceptibility in a Chinese population.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Anti-Tuberculosis Drug-Induced Liver Injury in Shanghai: Validation of Hy's Law
    Shen, Xin
    Yuan, Zheng'an
    Mei, Jian
    Zhang, Zurong
    Guo, Juntao
    Wu, Zheyuan
    Wu, Jie
    Zhang, Haihua
    Pan, Jieping
    Huang, Wenming
    Gong, Huili
    Yuan, Dong
    Xiao, Ping
    Wang, Yanqin
    Shuai, Yi
    Lin, Senlin
    Pan, Qichao
    Zhou, Tong
    Watkins, Paul B.
    Wu, Fan
    DRUG SAFETY, 2014, 37 (01) : 43 - 51
  • [32] NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis
    Suvichapanich, Supharat
    Fukunaga, Koya
    Zahroh, Hilyatuz
    Mushiroda, Taisei
    Mahasirimongkol, Surakameth
    Toyo-oka, Licht
    Chaikledkaew, Usa
    Jittikoon, Jiraphun
    Yuliwulandari, Rika
    Yanai, Hideki
    Wattanapokayakit, Sukanya
    Tokunaga, Katsushi
    PHARMACOGENETICS AND GENOMICS, 2018, 28 (07) : 167 - 176
  • [33] Possible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: A matched case-control study
    Yang, Miaomiao
    Zhang, Haiping
    Tao, Bilin
    Pan, Hongqiu
    Lu, Lihuan
    Yi, Honggang
    Tang, Shaowen
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (04) : 534 - 542
  • [34] Risk factors for acute liver failure among inpatients with anti-tuberculosis drug-induced liver injury
    Wang, Shuting
    Shangguan, Yanwan
    Ding, Cheng
    Li, Pengcheng
    Ji, Zhongkang
    Shao, Jundan
    Fang, Hong
    Yang, Meifang
    Shi, Pei
    Wu, Jie
    Ren, Jingjing
    Yang, Shigui
    Yuan, Jing
    Shi, Yunzhen
    Li, Jingnan
    Li, Lanjuan
    Xu, Kaijin
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (01)
  • [35] Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohort
    Moosa, Muhammed Shiraz
    Maartens, Gary
    Gunter, Hannah
    Allie, Shaazia
    Chughlay, Mohamed F.
    Setshedi, Mashiko
    Wasserman, Sean
    Stead, David F.
    Cohen, Karen
    SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2022, 23 (01) : 1 - 5
  • [36] NAT2 slow acetylator is associated with anti-tuberculosis drug-induced liver injury severity in indonesian population
    Yuliwulandari, Rika
    Prayuni, Kinasih
    Susilowati, Retno Wilujeng
    Subagyo
    Soedarsono
    Sofro, Abdul Salam M.
    Tokunaga, Katsushi
    Shin, Jae-Gook
    PHARMACOGENOMICS, 2019, 20 (18) : 1303 - 1311
  • [37] Anti-tuberculosis drug-induced liver injury in patient with hepatitis B and cirrhosis: A case report
    Aminy, Rusdi Zakki
    Kholili, Ulfa
    ANNALS OF MEDICINE AND SURGERY, 2022, 80
  • [38] Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity
    Singla, Neha
    Gupta, Dheeraj
    Birbian, Niti
    Singh, Jagtar
    TUBERCULOSIS, 2014, 94 (03) : 293 - 298
  • [39] Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Review
    Ambreen, Khushboo
    Sharma, Rolee
    Singh, Kaleshwar P.
    Kumar, Sudhir
    INTERNATIONAL JOURNAL OF ADVANCED BIOTECHNOLOGY AND RESEARCH, 2014, 5 (03): : 423 - 437
  • [40] Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity
    Chen, Ru
    Wang, Jing
    Zhang, Yuan
    Tang, Shaowen
    Zhan, Siyan
    ARCHIVES OF TOXICOLOGY, 2015, 89 (06) : 883 - 897